Edwards Lifesciences Corporation (EW)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 58.08B |
| Enterprise value | 57.27B |
| Trailing P/E | 38.44 |
| Forward P/E | 36.23 |
| PEG ratio (5-yr expected) | 2.89 |
| Price/sales (ttm) | 11.00 |
| Price/book (mrq) | 9.94 |
| Enterprise value/revenue | 10.69 |
| Enterprise value/EBITDA | 29.90 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.16 |
| 52-week change 3 | -1.18% |
| S&P500 52-week change 3 | -7.05% |
| 52-week high 3 | 131.73 |
| 52-week low 3 | 91.52 |
| 50-day moving average 3 | 110.64 |
| 200-day moving average 3 | 114.37 |
Share statistics
| Avg vol (3-month) 3 | 2.76M |
| Avg vol (10-day) 3 | 2.9M |
| Shares outstanding 5 | 621.75M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 616.25M |
| % held by insiders 1 | 0.79% |
| % held by institutions 1 | 85.12% |
| Shares short (28 Apr 2022) 4 | 4.86M |
| Short ratio (28 Apr 2022) 4 | 1.64 |
| Short % of float (28 Apr 2022) 4 | 0.79% |
| Short % of shares outstanding (28 Apr 2022) 4 | 0.78% |
| Shares short (prior month 30 Mar 2022) 4 | 4.46M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 3:1 |
| Last split date 3 | 31 May 2020 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 30 Mar 2022 |
Profitability
| Profit margin | 28.72% |
| Operating margin (ttm) | 30.69% |
Management effectiveness
| Return on assets (ttm) | 13.15% |
| Return on equity (ttm) | 29.30% |
Income statement
| Revenue (ttm) | 5.36B |
| Revenue per share (ttm) | 8.60 |
| Quarterly revenue growth (yoy) | 10.20% |
| Gross profit (ttm) | 3.98B |
| EBITDA | 1.78B |
| Net income avi to common (ttm) | 1.54B |
| Diluted EPS (ttm) | 2.43 |
| Quarterly earnings growth (yoy) | 10.50% |
Balance sheet
| Total cash (mrq) | 1.5B |
| Total cash per share (mrq) | 2.41 |
| Total debt (mrq) | 688.2M |
| Total debt/equity (mrq) | 11.77 |
| Current ratio (mrq) | 3.41 |
| Book value per share (mrq) | 9.41 |
Cash flow statement
| Operating cash flow (ttm) | 1.72B |
| Levered free cash flow (ttm) | 1.12B |
© 2022 Yahoo. All rights reserved.
